Clinical Trial Update: A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of sarpogrelate on blood hyperviscosity in peripheral artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Yuhan Corporation | Conditions: Peripheral Artery Disease, PAD | Phase 4 | Status: COMPLETED